Overview
Ryujiro Suzuki practices practicing medicine in Toyohashi, Japan.
Suzuki is highly rated in 1 condition, according to our data. Their clinical expertise encompasses EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Lymphofollicular Hyperplasia.
They are actively involved in clinical research, co-authoring 13 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ryujiro Suzuki
Is Ryujiro Suzuki a top-rated expert for EGFR Positive Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Ryujiro Suzuki is classified as an Advanced expert for EGFR Positive Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ryujiro Suzuki participate in research or clinical trials?
Yes. Ryujiro Suzuki has published 13 articles and abstracts on conditions like EGFR Positive Lung Cancer. You can view a list of Ryujiro Suzuki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerSuzuki isAdvanced. Learn about EGFR Positive Lung Cancer.
- Experienced
- Lung CancerSuzuki isExperienced. Learn about Lung Cancer.
- Lymphofollicular HyperplasiaSuzuki isExperienced. Learn about Lymphofollicular Hyperplasia.
- Non-Small Cell Lung Cancer (NSCLC)